Strategic Blueprint’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Sell |
9,961
-42
| -0.4% | -$7.8K | 0.09% | 201 |
|
|
2025
Q1 | $2.1M | Sell |
10,003
-280
| -3% | -$58.7K | 0.11% | 170 |
|
|
2024
Q4 | $1.83M | Buy |
10,283
+179
| +2% | +$31.8K | 0.11% | 168 |
|
|
2024
Q3 | $2M | Sell |
10,104
-1,232
| -11% | -$243K | 0.12% | 151 |
|
|
2024
Q2 | $1.94M | Buy |
11,336
+200
| +2% | +$34.3K | 0.13% | 144 |
|
|
2024
Q1 | $2.03M | Buy |
11,136
+686
| +7% | +$125K | 0.14% | 145 |
|
|
2023
Q4 | $1.62M | Sell |
10,450
-856
| -8% | -$133K | 0.13% | 155 |
|
|
2023
Q3 | $1.69M | Buy |
11,306
+286
| +3% | +$42.6K | 0.16% | 140 |
|
|
2023
Q2 | $1.48M | Buy |
11,020
+72
| +0.7% | +$9.7K | 0.14% | 147 |
|
|
2023
Q1 | $1.74M | Buy |
10,948
+812
| +8% | +$129K | 0.18% | 129 |
|
|
2022
Q4 | $1.64M | Buy |
10,136
+177
| +2% | +$28.6K | 0.19% | 127 |
|
|
2022
Q3 | $1.34M | Buy |
9,959
+807
| +9% | +$108K | 0.16% | 139 |
|
|
2022
Q2 | $1.4M | Buy |
9,152
+207
| +2% | +$31.7K | 0.17% | 131 |
|
|
2022
Q1 | $1.45M | Sell |
8,945
-817
| -8% | -$132K | 0.17% | 128 |
|
|
2021
Q4 | $1.32M | Buy |
9,762
+1,352
| +16% | +$183K | 0.17% | 135 |
|
|
2021
Q3 | $907K | Sell |
8,410
-1,037
| -11% | -$112K | 0.14% | 149 |
|
|
2021
Q2 | $1.06M | Buy |
9,447
+1,239
| +15% | +$140K | 0.17% | 125 |
|
|
2021
Q1 | $888K | Buy |
8,208
+784
| +11% | +$84.8K | 0.19% | 118 |
|
|
2020
Q4 | $795K | Buy |
7,424
+547
| +8% | +$58.6K | 0.2% | 102 |
|
|
2020
Q3 | $602K | Buy |
+6,877
| New | +$602K | 0.19% | 101 |
|
|
2019
Q4 | – | Sell |
-1,735
| Closed | -$131K | – | 93 |
|
|
2019
Q3 | $131K | Buy |
+1,735
| New | +$131K | 0.1% | 86 |
|
|
2019
Q1 | – | Sell |
-11,255
| Closed | -$1.04M | – | 72 |
|
|
2018
Q4 | $1.04M | Buy |
+11,255
| New | +$1.04M | 1.51% | 22 |
|